Martin Steegmaier

Martin Steegmaier, Ph.D., serves as Chief Scientific Officer and member of the Management Board at Molecular Partners. A seasoned R&D leader with extensive experience in oncology, biologics, and antibody engineering, he has held senior scientific leadership positions across both biotechnology and pharmaceutical companies. Before joining Molecular Partners, he was Chief Scientific Officer at SOTIO Biotech, leading the development of a diversified oncology pipeline. Earlier in his career, Martin served as Head of Research at MorphoSys and held senior leadership roles at Roche and Boehringer Ingelheim, where he contributed to the discovery and development of innovative therapeutic approaches across oncology and multiple disease areas.